Preclinical Evaluation of Radium-223 and Immune Checkpoint Inhibitors Using an Immune-Competent Model of Prostate Cancer Bone Metastases. - Lilieholm C; Adeniyi AO; Kwon O; Zaborek J; Kerr CP; Rojas HC; Idrissou MB; Ferreira CA; Clark PA; Jin WJ; Grudzinski JJ; Erbe AK; et al. (Precision oncology, 2026)